Trial Profile
Effect of Natalizumab withdrawal on relapse risk in Multiple Sclerosis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 12 Dec 2015 New trial record